-

Test and Treat – Still Vital as a New HIV Variant Emerges, says AHF

LOS ANGELES--(BUSINESS WIRE)--In response to the recent discovery of a more virulent subtype variant of HIV in the Netherlands, AIDS Healthcare Foundation (AHF) calls for the redoubling of global efforts to expand access to antiretroviral treatment (ART) and rapid HIV testing.

“The study published in Science estimates that people diagnosed with the newly discovered subtype-B variant can, on average, develop advanced HIV disease substantially faster than people with other subtype variants, if they are not on treatment,” said Dr. Jorge Saavedra, Executive Director of the AHF Global Public Health Institute at the University of Miami. “This means early HIV detection and treatment initiation, along with robust genomic sequencing capacity, are as important as ever, especially when COVID-19 has stretched public health resources thin around the world.”

“With at least 10 million people worldwide not receiving ART, AIDS is still very much a global pandemic crisis,” added Saavedra. “What’s more, COVID-19 is showing us how dangerous new variants can be when a pandemic is not under control; therefore, we must continue calling on our leaders to keep the promise on AIDS and keep funding the global response.”

Researchers say the new subtype variant has circulated in the Netherlands since the 1990s and remains receptive to treatment. To read more about the study, visit https://www.science.org/doi/10.1126/science.abk1688.

AHF provides rapid HIV testing, prevention services, and linkage to care in the Netherlands. For more information on our services, click here.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

AIDS Healthcare Foundation


Release Versions

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

More News From AIDS Healthcare Foundation

AHF Hails Introduction of Protect 340B Act of 2026

WASHINGTON--(BUSINESS WIRE)--AHF Hails Introduction of Protect 340B Act of 2026...

AHF Urges African Nations to Take Charge of Medicines Regulation

KIGALI, Rwanda--(BUSINESS WIRE)--With more than 20 African Union Member States yet to ratify the African Medicines Agency (AMA) Treaty, AIDS Healthcare Foundation (AHF) calls on African governments to accelerate ratification and regulatory harmonisation to expand access to affordable medicines and unlock Africa’s pharmaceutical manufacturing potential.The call comes as AMA convenes its inaugural week in Kigali, Rwanda, from 25–30 October 2026, against a backdrop of continued dependence on import...

Treatment = Life: AHF Reaches 2 Million Patients in Care in Africa

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) has surpassed 2 million patients in care across 15 African countries, marking a historic achievement 25 years after beginning its first programs outside the United States in South Africa and Uganda. With programs in four additional countries expected to launch in 2027, AHF is recognizing the communities and partnerships behind this progress while calling for urgent action to close persistent gaps in the HIV response. AHF’s work...
Back to Newsroom